Scoping Review on Gonadal Effects in Patients with Pelvic Irradiation
Main Article Content
Abstract
This scoping review aimed to review studies on gonadal effects and time of recovery post-irradiation, and the approaches taken to manage the condition. A literature search was performed via three directories and databases including PubMed, Cochrane Library and Google Scholar. A total of 41 articles fulfilled the inclusion criteria of the study. The study populations primarily involved rectal cancer and Hodgkin’s lymphoma. In general, there were 65 % of cases reported in female involved ovarian failure and dysfunction, while 36.4 % of cases reported in male showed hypogonadism, as the side effects from pelvic irradiation. The most common interventions were pre-treatment inter- ventions, such as ovarian transposition. However, information on the time of recovery was limited from these studies. The review shows that more evidences exist for the potency and effectiveness of pre-treatment interventions such as ovarian transposition in preserving the ovarian function post pelvic irradiation. Expansion of this review on participants with identical criteria can be performed, to permit further understanding of the post-irradiation gonadal effects.
Downloads
Article Details
References
Allison RR, Patel RM, McLawhorn RA. Radiation oncology: physics advances that minimize morbidity. Futur Oncol. 2014;10(15):2329–44.
Barnett GC, West CML, Dunning AM, Elliott RM, Coles CE, Pharoah PDP, et al. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer. 2009;9(2):134.
Kerns SL, Ostrer H, Rosenstein BS. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov. 2014 Feb;4(2):155– 65.
Dong L, Cui J, Tang F, Cong X, Han F. Ataxia telangiectasia–mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2015;91(5):1090–8.
Song Y-Z, Han F-J, Liu M, Xia C-C, Shi W-Y, Dong L-H. Association between single nucleotide polymorphisms in XRCC3 and radiation-induced adverse effects on normal tissue: a meta-analysis. PLoS One. 2015;10(6):e0130388.
Katz A. Quality of life for men with prostate cancer. Cancer Nurs. 2007;30(4):302–8.
Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6(4):209–18.
Hassan I, Cima RR. Quality of life after rectal resection and multimodality therapy. J Surg Oncol. 2007;96(8):684–92.
Chiarelll AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964–1988 in Ontario, Canada. Am J Epidemiol. 1999;150(3):245–54.
Pickles TOM, Graham P, INITIATIVE* BCCAPCO. What happens to testosterone after prostate radiation monotherapy and does it matter? J Urol. 2002;167(6):2448–52.
Richardson A, Addington-Hall J, Amir Z, Foster C, Stark D, Armes J, et al. Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review. Br J Cancer. 2011;105(S1):S82.
Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys [Internet]. 2009 Apr 1;73(5):1304–12. Available from: https://pubmed.ncbi.nlm.nih.gov/19306747
Bryant-Lukosius D, Browne G, DiCenso A, Whelan T, Gafni A, Neville A, et al. Evaluating health- related quality of life and priority health problems in patients with prostate cancer: a strategy for defining the role of the advanced practice nurse. Can Oncol Nurs Journal/Revue Can soins Infirm en Oncol. 2010;20(1):5–14.
Han S, Kim YH, Lee S, Kim GJ, Kim HJ, Kim JW, et al. Underuse of ovarian transposition in reproductive-aged cancer patients treated by primary or adjuvant pelvic irradiation. J Obstet Gynaecol Res. 2011;37(7):825–9.
Buchli C, Martling A, Arver S, Holm T. Testicular function after radiotherapy for rectal cancer—A review. J Sex Med. 2011;8(11):3220–6.
Johansen N, Liavaag AH, Tanbo TG, Dahl AA, Pripp AH, Michelsen TM. Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy. Gynecol Oncol. 2016;140(1):101–6.
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–59.
Buekers TE, Anderson B, Sorosky JI, Buller RE. Ovarian function after surgical treatment for cervical cancer. Gynecol Oncol. 2001;80(1):85–8.
Al-Badawi IA, Al-Aker M, AlSubhi J, Salem H, Abduljabbar A, Balaraj K, et al. Laparoscopic ovarian transposition before pelvic irradiation: a Saudi tertiary center experience. Int J Gynecol Cancer. 2010;20(6):1082–6.
Cowles RA, Gewanter RM, Kandel JJ. Ovarian repositioning in pediatric cancer patients: Flexible techniques accommodate pelvic radiation fields. Pediatr Blood Cancer. 2007;49(3):339–41.
Hwang JH, Yoo HJ, Park SH, Lim MC, Seo S-S, Kang S, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril. 2012;97(6):1387–93.
Schuck A, Hamelmann V, Brämswig JH, Könemann S, Rübe C, Hesselmann S, et al. Ovarian function following pelvic irradiation in prepubertal and pubertal girls and young adult women. Strahlentherapie und Onkol. 2005;181(8):534–9.
Morice P, Juncker L, Rey A, El-Hassan J, Haie-Meder C, Castaigne D. Ovarian transposition for patients with cervical carcinoma treated by radiosurgical combination. Fertil Steril. 2000;74(4):743–8.
Terenziani M, Piva L, Meazza C, Gandola L, Cefalo G, Merola M. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril. 2009;91(3):935-e15.
Wu XH, Li ZT, Huang X, Zhou YQ, Cheng X, Cai SM, et al. Transposed ovarian function conservation in cervical cancer patients with radiotherapy. Zhonghua Fu Chan Ke Za Zhi. 2005;40(4):220–2.
Swift BE, Leung E, Vicus D, Covens A. Laparoscopic ovarian transposition prior to pelvic radiation for gynecologic cancer. Gynecol Oncol reports. 2018;24:78–82.
Yamamoto R, Okamoto K, Yukiharu T, Kaneuchi M, Negishi H, Sakuragi N, et al. A study of risk factors for ovarian metastases in stage Ib–IIIb cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol. 2001;82(2):312–6.
Gubbala K, Laios A, Gallos I, Pathiraja P, Haldar K, Ind T. Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. J Ovarian Res. 2014;7(1):69.
Pahisa J, Martinez-Roman S, Martinez-Zamora MA, Torné A, Caparros X, Sanjuan A, et al. Laparoscopic ovarian transposition in patients with early cervical cancer. Int J Gynecol Cancer. 2008;18(3):584–9.
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010 Jun;152(11):726–32.
Kaste SC, Metzger ML, Minhas A, Xiong Z, Rai SN, Ness KK, et al. Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits. Pediatr Blood Cancer. 2009;52(4):516–21.
Kiserud CE, Fosså A, Holte H, Fosså SD. Post- treatment parenthood in Hodgkin’s lymphoma survivors. Br J Cancer. 2007;96(9):1442.